HEROHE's dataset is publicly available for research purposes under the Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) license. The citation should refer to 10.3390/jimaging8080213. Teams should notify the organizers of the challenge about any publication (partly) based on the results or data published on this site. The challenge organizers will maintain a public list of publications associated with the challenge so others may find appropriate references easily.

  Last edition:        
                      Aug 05, 2022

List of Associated Publications¶

Conde-Sousa et al., HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin–Eosin Whole-Slide Imaging, 2022, J. Imaging, ; 8(8):213; DOI: 10.3390/jimaging8080213

Conde-Sousa E., Vale J., Feng M., Xu K., Wang Y., Della Mea V., La Barbera D., Montahaei E., Baghshah M. S., Turzynski, A., Gildenblat J., Klaiman E., Hong Y., Aresta G., Araújo T., Aguiar P., Eloy C., Polónia A., HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization, arXiv:2111.04738
La Barbera, D., Polónia, A., Roitero, K., Conde-Sousa , E., Della Mea, V. Detection of HER2 from Haematoxylin-Eosin Slides Through a Cascade of Deep Learning Classifiers via Multi-Instance Learning (2020) J. Imaging, 6(9), 82; DOI: 10.3390/jimaging6090082